ECG Stock Analysis: Everus Construction | NYSE
Engineering & Construction | NYSE, USA | Market Cap: 7.057m USD | 12M Return: 105.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 97.9M
Qual. Beats: 0
Rev. Trend: 86.3%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 1.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Everus Construction Group, Inc. (NYSE: ECG) is a U.S.-based contracting services provider operating through two segments: Electrical & Mechanical and Transmission & Distribution. The Electrical & Mechanical segment delivers construction and maintenance services for electrical and communication wiring, fire suppression systems, and renewables infrastructure and mechanical piping. The Transmission & Distribution segment focuses on overhead and underground electrical, gas, and communication infrastructure, along with related transportation lighting, and includes the design, manufacturing, and distribution of transmission line construction equipment and tools. The company serves a diverse customer base spanning utilities, manufacturing, transportation, commercial, industrial, institutional, renewables, and governmental sectors, and is headquartered in Bismarck, North Dakota.
Within the Construction & Engineering sub-industry, ECGs business model is distinguished by vertical integration, combining in-house engineering, manufacturing, and field installation capabilities, which allows the company to supply both services and proprietary equipment to utility and infrastructure clients. Its exposure to renewables and grid modernization projects aligns the company with ongoing U.S. investment in power infrastructure upgrades and the energy transition.
- Transmission & Distribution segment grows on grid modernization spending
- Electrical & Mechanical demand surges from data center and renewables buildout
- Federal infrastructure bill funding expands utility project backlog
| Net Income: 223.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.55 > 1.0 |
| NWC/Revenue: 15.60% < 20% (prev 13.93%; Δ 1.67% < -1%) |
| CFO/TA 0.16 > 3% & CFO 293.4m > Net Income 223.4m |
| Net Debt (153.8m) to EBITDA (345.6m): 0.44 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.2m) vs 12m ago 0.19% < -2% |
| Gross Margin: 12.44% > 18% (prev 11.71%; Δ 0.73% > 0.5%) |
| Asset Turnover: 247.0% > 50% (prev 225.0%; Δ 22.02% > 0%) |
| Interest Coverage Ratio: 17.04 > 6 (EBIT TTM 315.6m / Interest Expense TTM 18.5m) |
| A: 0.33 (Total Current Assets 1.42b - Total Current Liabilities 804.0m) / Total Assets 1.85b |
| B: 0.29 (Retained Earnings 544.1m / Total Assets 1.85b) |
| C: 0.20 (EBIT TTM 315.6m / Avg Total Assets 1.60b) |
| D: 0.59 (Book Value of Equity 686.9m / Total Liabilities 1.16b) |
| Altman-Z'' = 5.10 = AAA |
| DSRI: 0.74 (Receivables 781.6m/814.7m, Revenue 3.96b/3.05b) |
| GMI: 0.94 (GM 11.71% / 12.44%) |
| AQI: 0.73 (AQ_t 0.09 / AQ_t-1 0.13) |
| SGI: 1.30 (Revenue 3.96b / 3.05b) |
| TATA: -0.04 (NI 223.4m - CFO 293.4m) / TA 1.85b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at USD 134.30 with a total of 681,456 shares traded. Over the past week, the price has changed by -19.07%, over one month by -12.07%, over three months by +4.72% and over the past year by +105.63%.
Current recommended Stop Loss: 121.50 (which is 9.5% or 1.3 ATR below the current price).
Everus Construction has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ECG.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 169.6 | 26.3% |
P/E Trailing = 31.6384
P/E Forward = 36.3636
P/S = 1.7836
P/B = 11.2212
Revenue TTM = 3.96b USD
EBIT TTM = 315.6m USD
EBITDA TTM = 345.6m USD
Long Term Debt = 263.0m USD (from longTermDebt, last quarter)
Short Term Debt = 47.9m USD (from shortTermDebt, last quarter)
Debt = 447.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 84.6m
Net Debt = 153.8m USD (calculated: Debt 447.2m - CCE 293.4m)
Enterprise Value = 7.21b USD (7.06b + Debt 447.2m - CCE 293.4m)
Interest Coverage Ratio = 17.04 (Ebit TTM 315.6m / Interest Expense TTM 18.5m)
EV/FCF = 31.40x (Enterprise Value 7.21b / FCF TTM 229.6m)
FCF Yield = 3.18% (FCF TTM 229.6m / Enterprise Value 7.21b)
FCF Margin = 5.80% (FCF TTM 229.6m / Revenue TTM 3.96b)
Net Margin = 5.65% (Net Income TTM 223.4m / Revenue TTM 3.96b)
Gross Margin = 12.44% ((Revenue TTM 3.96b - Cost of Revenue TTM 3.46b) / Revenue TTM)
Gross Margin QoQ = 12.61% (prev 11.62%)
Tobins Q-Ratio = 3.90 (Enterprise Value 7.21b / Total Assets 1.85b)
Interest Expense / Debt = 4.14% (Interest Expense 18.5m / Debt 447.2m)
Taxrate = 25.47% (76.4m / 299.8m)
NOPAT = 235.2m (EBIT 315.6m * (1 - 25.47%))
Current Ratio = 1.77 (Total Current Assets 1.42b / Total Current Liabilities 804.0m)
Debt / Equity = 0.65 (Debt 447.2m / totalStockholderEquity, last quarter 686.9m)
Debt / EBITDA = 0.44 (Net Debt 153.8m / EBITDA 345.6m)
Debt / FCF = 0.67 (Net Debt 153.8m / FCF TTM 229.6m)
Total Stockholder Equity = 601.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.95% (Net Income 223.4m / Total Assets 1.85b)
RoE = 37.17% (Net Income TTM 223.4m / Total Stockholder Equity 601.1m)
RoCE = 36.53% (EBIT 315.6m / Capital Employed (Equity 601.1m + L.T.Debt 263.0m))
RoIC = 26.32% (NOPAT 235.2m / Invested Capital 893.8m)
WACC = 13.67% (E(7.06b)/V(7.50b) * Re(14.34%) + D(447.2m)/V(7.50b) * Rd(4.14%) * (1-Tc(0.25)))
Discount Rate = 14.34% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 93.09 | Cagr: 0.19%
[DCF] Terminal Value 62.73% ; FCFF base≈175.1m ; Y1≈200.7m ; Y5≈295.3m
[DCF] Fair Price = 41.59 (EV 2.28b - Net Debt 153.8m = Equity 2.12b / Shares 51.0m; r=13.67% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.02 | # QB: 0
Revenue Correlation: 86.34 | Revenue CAGR: 14.56% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.14 | Chg30d=+4.59% | Revisions=+0% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.18 | Chg30d=+5.00% | Revisions=+0% | Analysts=5
EPS current Year (2026-12-31): EPS=4.62 | Chg30d=+11.49% | Revisions=+57% | GrowthEPS=+16.9% | GrowthRev=+16.8%
EPS next Year (2027-12-31): EPS=5.11 | Chg30d=+10.89% | Revisions=+57% | GrowthEPS=+10.6% | GrowthRev=+10.4%
[Analyst] Revisions Ratio: +53% (up=10, down=2)